Denise Carter
Board Member
Quoin Pharmaceuticals Ltd. (QNRX)Equibles does not estimate personal net worth.
Get an email with a short summary when Quoin Pharmaceuticals Ltd. publishes a filing, an earnings call transcript or a press release.
Get QNRX alertsAbout Denise Carter
Denise Carter is recorded as COO and Board Member at Quoin Pharmaceuticals Ltd. (QNRX). The newest filing on record that lists Denise Carter as COO and Board Member at Quoin Pharmaceuticals Ltd. (QNRX) is dated July 16, 2026. Quoin Pharmaceuticals Ltd. reported in an 8-K filed August 20, 2026 that Denise Carter was appointed director, effective August 20, 2026. Quoin Pharmaceuticals Ltd. reported in an 8-K filed December 10, 2024 that Denise Carter was appointed Director, effective December 5, 2024. Quoin Pharmaceuticals Ltd. reported in an 8-K filed November 1, 2023 that Denise Carter was appointed director, effective October 26, 2023. The proxy statement of Quoin Pharmaceuticals Ltd. reports total compensation of $1,282,285 for Denise Carter in fiscal 2025, including a base salary of $595,440. Disclosed compensation is on record for 4 fiscal years. Quoin Pharmaceuticals Ltd. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Quoin Pharmaceuticals Ltd. includes Dr. Michael Myers (CEO and Board Member), Sally Lawlor (CFO and Chief Accounting Officer), Dr. Dennis H. Langer (Board Member) and 4 others.
“The shareholders elected the following directors to serve as a director of the Company until the Company's next annual general meeting of shareholders and until such director's successor is duly elected and qualified, or until such director's earlier resignation or retirement, based upon the following votes:”
“The shareholders elected the following directors to serve on Quoin's Board of Directors until Quoin's 2025 annual meeting of shareholders and until such director's successor is duly elected and qualified, or until such director's earlier resignation or retirement, based upon the following votes:”
Affiliation history
-
Current
Start not stated–present
Last confirmed July 16, 2026
-
Current
Start not stated–present
Last confirmed July 16, 2026
Company network
Leadership on record at Quoin Pharmaceuticals Ltd.
- Dr. Michael Myers CEO, Board Member
- Sally Lawlor CFO, Chief Accounting Officer
- Dr. Dennis H. Langer Board Member
- James Culverwell Board Member
- Joseph Cooper Board Member
- Michael Sember Board Member
- Natalie Leong Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Quoin Pharmaceuticals Ltd. (QNRX) | Chief Operating Officer | $595,440 | $1,282,285 |
| 2024 | Quoin Pharmaceuticals Ltd. (QNRX) | Chief Operating Officer | $529,980 | $1,211,612 |
| 2023 | Quoin Pharmaceuticals Ltd. (QNRX) | Chief Operating Officer | $481,800 | $1,070,966 |
| 2022 | Quoin Pharmaceuticals Ltd. (QNRX) | Chief Operating Officer | $440,000 | $1,805,402 |